Cardiac consequences of hypertension in hemodialysis patients

Seminars in Dialysis

Volumn 17, Issue 4, 2004, Pages 299-303

  Zoccali, Carmine ^a   Benedetto, Francesco Antonio ^b   Tripepi, Giovanni ^a   Mallamaci, Francesca ^a  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^b Morelli Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARVEDILOL; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTERIAL PRESSURE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MORTALITY; PATHOGENESIS; PREDICTION; REVIEW; RISK FACTOR; STROKE; ULTRAFILTRATION;

ARRHYTHMIA; CORONARY DISEASE; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 4243184788     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0894-0959.2004.17331.x     Document Type: Review

References (54)

1. Zoccali C, Mallamaci F, Tripepi G: Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 85:105-110, 2003
2. Faber RL: http://users.rcn.com/ktda1/Years_on_Dialysis.pdf
3. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(5 suppl 3):S112-S119, 1998
4. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34:125-134, 1999
5. Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK: Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. Am J Nephrol 21:280-288, 2001
6. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS: Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 12:2768-2774, 2001
7. Zoccali C, Mallamaci F, Tripepi G: Inflammation and atherosclerosis in end-stage renal disease. Blood Purif 21:29-36, 2003
8. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54:561-569, 1998
9. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 33:507-517, 1999
10. Cox JP, O'Brien E, O'Malley K: The J-shaped curve in elderly hypertensives. J Hypertens Suppl 10:S17-S23, 1992
11. Charra B, Calemard M, Laurent G: Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 16:35-44, 1996
12. Lynn KL, McGregor DO, Moesbergen T, Buttimore AL, Inkster JA, Wells JE: Hypertension as a determinant of survival for patients treated with home dialysis. Kidney Int 62:2281-2287, 2002
13. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
14. Zoccali C: Arterial pressure components and cardiovascular risk in end-stage renal disease. Nephrol Dial Transplant 18:249-252, 2003
15. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cottini E, Giacone G, Malatino L: Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. J Hypertens 17(12 pt 1):1751-1758, 1999
16. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286-290, 1989
17. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024-2031, 1995
18. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759-2767, 2001
19. Devereux RB, Roman MJ: Hypertensive cardiac hypertrophy: pathophysiologic and clinical characteristics. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management, 2nd ed. New York: Raven Press, 1995:409-424
20. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 11:912-916, 2000
21. Ozkahya M, Ok E, Cirit M, Aydin S, Akcicek F, Basci A, Dorhout Mees EJ: Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 13:1489-1493, 1998
22. Woods JD, Port FK, Orzol S, Buoncristiani U, Young E, Wolfe RA, Held PJ: Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 55:2467-2476, 1999
23. Raj DS, Charra B, Pierratos A, Work J: In search of ideal hemodialysis: is prolonged frequent dialysis the answer? Am J Kidney Dis 34:597-610, 1999
24. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61:2235-2239, 2002
25. Lin YP, Chen CH, Yu WC, Hsu TL, Ding PY, Yang WC: Left ventricular mass and hemodynamic overload in normotensive hemodialysis patients. Kidney Int 62:1828-1838, 2002
26. Zhang R, Crump J, Reisin E: Regression of left ventricular hypertrophy is a key goal of hypertension management. Curr Hypertens Rep 5:301-308, 2003
27. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL: Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 90:2786-2796, 1994
28. Cannella G, Paoletti E, Barocci S, Massarino F, Delfino R, Ravera G, Di Maio G, Nocera A, Patrone P, Rolla D: Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy. Kidney Int 54:618-626, 1998
29. Foley RN, Herzog CA, Collins AJ: Blood pressure and long-term mortality in United States hemodialysis patients. USRDS Waves 3 and 4 Study. Kidney Int 62:1784-1790, 2002
30. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS, Cataliotti A: Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105:1354-1359, 2002
31. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabro R: Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 41:1438-1444, 2003
32. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Sutton GC: Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350:1349-1353, 1997
33. Stack AG, Bloembergen WE: A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 38:992-1000, 2001
34. McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441-1446, 1971
35. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47:884-890, 1995
36. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, Grobbee DE: The epidemiology of heart failure. Eur Heart J 18:208-225, 1997
37. Stack AG, Bloembergen WE: Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 12:1516-1523, 2001
38. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903-1913, 2002
39. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 358:1305-1315, 2001
40. Rostand SG, Kirk KA, Rutsky EA: Dialysis-associated ischemic heart disease: insights from coronary angiography. Kidney Int 25:653-659, 1984
41. Rostand SG, Kirk KA, Rutsky EA: Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 22:304-308, 1982
42. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
43. Meier P, Vogt P, Blanc E: Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron 87:199-214, 2001
44. McLenachan JM, Henderson E, Morris KI, Dargie HJ: Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 317:787-792, 1987
45. Healey JS, Connolly SJ: Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cordiol 91(suppl 1):9-14, 2003
46. Gronefeld GC, Hohnloser SH: Heart failure complicated by atrial fibrillation, mechanistic, prognostic, and therapeutic implications. J Cardiovasc Pharmacol Ther 8:107-113, 2003
47. Verdecchia P, Reboldi G, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, Carluccio E, Sardone MG, Porcellati C: Atrial fibrillation in hypertension: predictors and outcome. Hypertension 41:218-223, 2003
48. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A: Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies of Left Ventricular Dysfunction (SOLVD) trials. Circulation 107:2926-2931, 2003
49. Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY: Atrial fibrillation in chronic dialysis patients in the United states: risk factors for hospitalization and mortality. BMC Nephrol 4:1, 2003
50. Ansari N, Manis T, Feinfeld DA: Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail 23:71-76, 2001
51. Gruppo Emodialisi e Patologie Cardiovasculari: Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients. Lancet 2:305-309, 1988
52. De Lima JJ, Lopes HF, Grupi CJ, Abensur H, Giorgi MC, Krieger EM, Pileggi F: Blood pressure influences the occurrence of complex ventricular arrhythmia in hemodialysis patients. Hypertension 26(6 pt 2):1200-1203, 1995
53. Zoccali C, Mallamaci F, Tripepi G, Parlongo S, Cutrupi S, Benedetto FA, Cataliotti A, Malatino LS: Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension 40:41-46, 2002
54. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA: Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340:1321-1328, 1999